• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

50岁及以上患与未患多发性硬化症成年人的结局与医疗服务利用情况:一项为期6年的观察性分析

Outcomes and Health Care Service Use in Adults 50 Years or Older With and Without Multiple Sclerosis: A 6-Year Observational Analysis.

作者信息

Freeman Leorah, Lucas Ashlea, Zhou Jia, Hayward Brooke, Gough Mallory, Livingston Terrie

机构信息

Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA (LF, AL).

EMD Serono, Rockland, MA, USA (JZ, BH, TL).

出版信息

Int J MS Care. 2023 Mar-Apr;25(2):56-62. doi: 10.7224/1537-2073.2021-124. Epub 2022 Sep 13.

DOI:10.7224/1537-2073.2021-124
PMID:36923575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10010108/
Abstract

BACKGROUND

Multiple sclerosis (MS) typically presents in young adulthood. Recent data show the highest prevalence of MS in people aged 55 to 64 years; however, there are limited studies of this population.

METHODS

Administrative US claims data from IBM-Truven MarketScan commercial and Medicare databases (2011-2017) were analyzed. People with MS 50 years or older were assigned to the aging MS cohort (n = 10,746). The matched controls were people 50 years or older without MS (n = 10,746). Multivariable models compared outcomes between groups.

RESULTS

Infections were more frequent in the aging MS cohort vs matched controls (61% vs 45%; < .0001); urinary tract, acute upper respiratory tract, and herpes zoster were the most frequent infection types. Malignancy rates were 20% for both groups ( = .8167); skin, breast, and prostate malignancies were the most frequent types. Skilled nursing facilities (aging MS cohort, 12%; matched controls, 3%; < .0001) and MRI (aging MS cohort, 87%; matched controls, 37%; < .0001) were used more frequently in the aging MS cohort; brain and spine were the most frequent types of MRI in the aging MS cohort. Time to first cane/walker or wheelchair use was shorter in the aging MS cohort (cane/walker use: HR, 2.1; 95% CI, 1.9-2.3; < .0001; wheelchair use: HR, 6.9; 95% CI, 6.0-8.1; < .0001).

CONCLUSIONS

In people 50 years or older, measures typically associated with worse health primarily resulted from having MS rather than being a consequence of aging alone.

摘要

背景

多发性硬化症(MS)通常在成年早期发病。近期数据显示,55至64岁人群中MS的患病率最高;然而,针对该人群的研究有限。

方法

分析了来自IBM - Truven MarketScan商业和医疗保险数据库(2011 - 2017年)的美国行政索赔数据。50岁及以上的MS患者被纳入老年MS队列(n = 10,746)。匹配的对照组为50岁及以上无MS的人群(n = 10,746)。多变量模型比较了两组之间的结果。

结果

老年MS队列中的感染发生率高于匹配的对照组(61%对45%;P <.0001);尿路感染、急性上呼吸道感染和带状疱疹是最常见的感染类型。两组的恶性肿瘤发生率均为20%(P =.8167);皮肤、乳腺和前列腺恶性肿瘤是最常见的类型。老年MS队列中更频繁使用专业护理机构(老年MS队列,12%;匹配对照组,3%;P <.0001)和MRI(老年MS队列,87%;匹配对照组,37%;P <.0001);脑部和脊柱是老年MS队列中最常见的MRI检查部位。老年MS队列中首次使用手杖/助行器或轮椅的时间更短(使用手杖/助行器:HR,2.1;95%CI,1.9 - 2.3;P <.0001;使用轮椅:HR,6.9;95%CI,6.0 - 8.1;P <.0001)。

结论

在50岁及以上人群中,通常与健康状况较差相关的指标主要是由患有MS导致的,而非仅仅是衰老的结果。

相似文献

1
Outcomes and Health Care Service Use in Adults 50 Years or Older With and Without Multiple Sclerosis: A 6-Year Observational Analysis.50岁及以上患与未患多发性硬化症成年人的结局与医疗服务利用情况:一项为期6年的观察性分析
Int J MS Care. 2023 Mar-Apr;25(2):56-62. doi: 10.7224/1537-2073.2021-124. Epub 2022 Sep 13.
2
Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world data.坚持疾病修正治疗对多发性硬化症长期临床和经济结局的影响:基于真实世界数据的索赔分析
Mult Scler Relat Disord. 2023 Sep;77:104866. doi: 10.1016/j.msard.2023.104866. Epub 2023 Jul 1.
3
Effectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: A real-world retrospective multicenter analysis.老年复发型多发性硬化症患者换用特立氟胺的有效性和安全性:一项真实世界回顾性多中心分析。
Mult Scler Relat Disord. 2023 Feb;70:104472. doi: 10.1016/j.msard.2022.104472. Epub 2022 Dec 18.
4
All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.美国新诊断多发性硬化症的全因医疗保健利用情况及相关费用。
J Manag Care Pharm. 2010 Nov-Dec;16(9):703-12. doi: 10.18553/jmcp.2010.16.9.703.
5
Direct health care costs associated with COVID-19 in the United States.美国与 COVID-19 相关的直接医疗保健成本。
J Manag Care Spec Pharm. 2022 Sep;28(9):936-947. doi: 10.18553/jmcp.2022.22050. Epub 2022 Jun 18.
6
A Retrospective, Longitudinal, Claims-Based Comparison of Concomitant Diagnoses Between Individuals with and Without Down Syndrome.一项回顾性、纵向、基于理赔的唐氏综合征患者与非唐氏综合征患者伴发诊断比较。
J Manag Care Spec Pharm. 2017 Jul;23(7):761-770. doi: 10.18553/jmcp.2017.23.7.761.
7
The prevalence and utility of screening for urinary tract infection at the time of presumed multiple sclerosis relapse.在疑似多发性硬化症复发时进行尿路感染筛查的流行率和实用性。
Mult Scler Relat Disord. 2019 Oct;35:61-66. doi: 10.1016/j.msard.2019.06.038. Epub 2019 Jul 2.
8
Risk of cancer among Finnish multiple sclerosis patients.芬兰多发性硬化症患者的癌症风险。
Mult Scler Relat Disord. 2019 Oct;35:221-227. doi: 10.1016/j.msard.2019.08.005. Epub 2019 Aug 5.
9
Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis.克拉屈滨片治疗多发性硬化症患者的安全性:综合分析。
Mult Scler Relat Disord. 2019 Apr;29:157-167. doi: 10.1016/j.msard.2018.11.021. Epub 2018 Nov 20.
10
Physical function across the lifespan in adults with multiple sclerosis: An application of the Short Physical Performance Battery.多发性硬化症成年人的全生命周期身体机能:短体适能电池的应用。
Mult Scler Relat Disord. 2023 May;73:104624. doi: 10.1016/j.msard.2023.104624. Epub 2023 Mar 20.

本文引用的文献

1
Assessing and mitigating risk of infection in patients with multiple sclerosis on disease modifying treatment.评估和减轻接受疾病修饰治疗的多发性硬化症患者的感染风险。
Expert Rev Clin Immunol. 2021 Mar;17(3):285-300. doi: 10.1080/1744666X.2021.1886924. Epub 2021 Mar 8.
2
Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.病毒感染对红斑狼疮和多发性硬化症患者癌症风险的影响。
PLoS One. 2021 Jan 22;16(1):e0243150. doi: 10.1371/journal.pone.0243150. eCollection 2021.
3
Cancer Incidence and Mortality Rates in Multiple Sclerosis: A Matched Cohort Study.多发性硬化症中的癌症发病率和死亡率:一项匹配队列研究。
Neurology. 2021 Jan 26;96(4):e501-e512. doi: 10.1212/WNL.0000000000011219. Epub 2020 Nov 25.
4
Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study.多发性硬化症患者逐年增加的癌症风险:一项病例对照研究。
J Neurol. 2021 Mar;268(3):817-824. doi: 10.1007/s00415-020-10170-5. Epub 2020 Oct 21.
5
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.多发性硬化症患者接受疾病修正治疗后的感染风险:德尔菲共识声明。
Mult Scler. 2021 Mar;27(3):331-346. doi: 10.1177/1352458520952311. Epub 2020 Sep 17.
6
Urinary tract infection in patients with multiple sclerosis: An overview.多发性硬化症患者的尿路感染:综述。
Mult Scler Relat Disord. 2020 Nov;46:102462. doi: 10.1016/j.msard.2020.102462. Epub 2020 Aug 27.
7
Infections in patients with multiple sclerosis: A national cohort study in Sweden.多发性硬化症患者的感染:瑞典的一项全国队列研究。
Mult Scler Relat Disord. 2020 Oct;45:102420. doi: 10.1016/j.msard.2020.102420. Epub 2020 Jul 23.
8
Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States.在美国密歇根州的一个大型 1305 名 COVID-19 患者队列中,年龄较大和合并症是独立的死亡预测因素。
J Intern Med. 2020 Oct;288(4):469-476. doi: 10.1111/joim.13119. Epub 2020 Jun 22.
9
Association between age and clinical characteristics and outcomes of COVID-19.年龄与 COVID-19 的临床特征和结局的关系。
Eur Respir J. 2020 May 27;55(5). doi: 10.1183/13993003.01112-2020. Print 2020 May.
10
Infections in patients diagnosed with multiple sclerosis: A multi-database study.多发性硬化症患者的感染:一项多数据库研究。
Mult Scler Relat Disord. 2020 Jun;41:101982. doi: 10.1016/j.msard.2020.101982. Epub 2020 Feb 4.